[1]
Kim, M.J. et al. 2023. Clinical Response to Low-dose Omalizumab Treatment in Chronic Spontaneous Urticaria: A Retrospective Study of 179 Patients. Acta Dermato-Venereologica. 103, (Aug. 2023), adv11627. DOI:https://doi.org/10.2340/actadv.v103.11627.